01. Technology
ProTrans
Milestones Achieved
Study Team
First indication: Type-1 Diabetes
Cellaviva
02. About NextCell
Business Concept
History
Market
Organisation
Company Structure
03. Investors
Rights Issue
Financial Calendar
Financial Reports
Corporate Governance
Certified Adviser
The Share
Archive
04. News
Press Releases
News
Company Presentations
Company Analyses
05. Contact
Contact Information
Subscribe
English
/
Svenska
05.
Contact
Want to know more? Contact us by mail or phone and subscribe to our news and press releases.
Karolinska Institutet Science Park
Hälsovägen 7, 141 57 Huddinge, Sweden
Map
Mathias Svahn, CEO
Sofia Fredrikson, CFO
Phone: +46 (0)8 735 55 95
Email:
info@nextcellpharma.com
Subscribe
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form. Please try again.